Clinical Trails of Photoelectrochemical Immunosensor for Early Diagnosis of Acute Myocardial Infarction
NCT ID: NCT04390490
Last Updated: 2020-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2020-10-01
2023-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiolabeled TSPO Targeted Molecular Probe in AMI
NCT07105982
Study of Coronary Artery Computed Tomography to Diagnose Emergency Chest Pain
NCT00273832
Association Between Peri-procedural Myocardial Injury and Quantitative Blood Flow Ratio
NCT07110298
Optical Coherence Tomography Examination in Acute Myocardial Infarction
NCT03593928
Ferumoxytol for Magnetic Resonance Imaging of Myocardial Infarction
NCT01323296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
Automatic chemiluminescence analyzer will be used for dectecting the concentration of cardiac troponin I as control group.
No interventions assigned to this group
Photoelectrochemical immunosensor
Photoelectrochemical immunosensor will be used for dectecting the concentration of cardiac troponin I as test group.
Graphene quantum dots combined with Si nanowire photoelectrochemical immunosensor
Graphene quantum dots combined with Si nanowire is a new method of photoelectrochemical immunosensor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Graphene quantum dots combined with Si nanowire photoelectrochemical immunosensor
Graphene quantum dots combined with Si nanowire is a new method of photoelectrochemical immunosensor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptoms of chest pain
Exclusion Criteria
* Lactating women
* Patients with mental disorders
* Patients are using other experimental drugs; Refusal to provide informed.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bin He
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bin He
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ethics Committee of Xinhua Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XH-20-007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.